Results 101 to 110 of about 12,311,631 (363)

A comparative study of circulating tumor cell isolation and enumeration technologies in lung cancer

Molecular Oncology, EarlyView.
Lung cancer cells were spiked into donor blood to evaluate the recovery rates of the following circulating tumor cell (CTC) enrichment technologies: CellMag™, EasySep™, RosetteSep™, Parsortix® PR1, and Parsortix® Prototype systems. Each method's advantages and disadvantages are described.
Volga M Saini, Ezgi Oner, Mark P. Ward, Sinead Hurley, Brian David Henderson, Faye Lewis, Stephen P. Finn, Gerard J. Fitzmaurice, John J. O'Leary, Sharon O'Toole, Lorraine O'Driscoll, Kathy Gately   +11 more
wiley   +1 more source

Loss of stem cell regenerative capacity within aged niches. [PDF]

, 2007
This work uncovers novel mechanisms of aging within stem cell niches that are evolutionarily conserved between mice and humans and affect both embryonic and adult stem cells.
Carlson, Morgan, CONBOY, Irina M
core   +3 more sources

Human hematopoietic stem/progenitor cells display reactive oxygen species-dependent long-term hematopoietic defects after exposure to low doses of ionizing radiations

Haematologica, 2020
Hematopoietic stem cells are responsible for life-long blood cell production and are highly sensitive to exogenous stresses. The effects of low doses of ionizing radiations on radiosensitive tissues such as the hematopoietic tissue are still unknown ...
Elia Henry, Inès Souissi-Sahraoui, Margaux Deynoux, Andréas Lefèvre, Vilma Barroca, Anna Campalans, Véronique Ménard, Julien Calvo, Françoise Pflumio, Marie-Laure Arcangeli   +9 more
doaj   +1 more source

Advances in Pluripotent Stem Cells: History, Mechanisms, Technologies, and Applications

Stem Cell Reviews and Reports, 2019
Over the past 20 years, and particularly in the last decade, significant developmental milestones have driven basic, translational, and clinical advances in the field of stem cell and regenerative medicine. In this article, we provide a systemic overview
Gele Liu, Brian T. David, Matthew Trawczynski, R. Fessler   +3 more
semanticscholar   +1 more source

Stemmed cells [PDF]

Current Biology, 2009
SummaryBritain's support for human-animal stem cell research seems to be faltering. Nigel Williams reports.
openaire   +1 more source

Cell‐free and extracellular vesicle microRNAs with clinical utility for solid tumors

Molecular Oncology, EarlyView.
Cell‐free microRNAs (cfmiRs) are small‐RNA circulating molecules detectable in almost all body biofluids. Innovative technologies have improved the application of cfmiRs to oncology, with a focus on clinical needs for different solid tumors, but with emphasis on diagnosis, prognosis, cancer recurrence, as well as treatment monitoring.
Yoshinori Hayashi, Janelle‐Cheri Millen, Romela Irene Ramos, Jennifer A. Linehan, Timothy G. Wilson, Dave S. B. Hoon, Matias A. Bustos   +6 more
wiley   +1 more source

Contribution of resident stem cells to liver and biliary tree regeneration in human diseases [PDF]

, 2018
Two distinct stem/progenitor cell populations of biliary origin have been identified in the adult liver and biliary tree. Hepatic Stem/progenitor Cells (HpSCs) are bipotent progenitor cells located within the canals of Hering and can be differentiated ...
Alvaro, Domenico, Cardinale, Vincenzo, Carpino, Guido, Franchitto, Antonio, Gaudio, Eugenio, Onori, Paolo, Overi, Diletta, Safarikia, Samira   +7 more
core   +1 more source

Stem Cell

, 2015
-
openaire   +3 more sources

Cellular liquid biopsy provides unique chances for disease monitoring, preclinical model generation and therapy adjustment in rare salivary gland cancer patients

Molecular Oncology, EarlyView.
We quantified and cultured circulating tumor cells (CTCs) of 62 patients with various cancer types and generated CTC‐derived tumoroid models from two salivary gland cancer patients. Cellular liquid biopsy‐derived information enabled molecular genetic assessment of systemic disease heterogeneity and functional testing for therapy selection in both ...
Nataša Stojanović Gužvić, Florian Lüke, Steffi Treitschke, Andrea Coluccio, Martin Hoffmann, Giancarlo Feliciello, Adithi Ravikumar Varadarajan, Xin Lu, Kathrin Weidele, Catherine Botteron, Silvia Materna–Reichelt, Felix Keil, Katja Evert, Florian Weber, Thomas Schamberger, Michael Althammer, Jirka Grosse, Dirk Hellwig, Christian Schulz, Stephan Seitz, Peter Ugocsai, Anke Schlenska‐Lange, Roman Mayr, Ulrich Kaiser, Wolfgang Dietmaier, Bernhard Polzer, Jens Warfsmann, Kamran Honarnejad, Tobias Pukrop, Daniel Heudobler, Christoph A. Klein, Christian Werno   +31 more
wiley   +1 more source

Stem cell decisions:A twist of fate or a niche market? [PDF]

, 2014
Establishing and maintaining cell fate in the right place at the right time is a key requirement for normal tissue maintenance. Stem cells are at the core of this process.
Anderson, Barker, Bellis, Bettencourt-Dias, Bowman, Brawley, Buczacki, Cabernard, Cairns, Callaini, Cao, Carmena, Castanon, Castanon, Chen, Cheng, Chrétien, Clevers, Conduit, Conti, Das, Delgehyr, Doe, Du, Durand, Falconer, Gillies, Gonzalez, Goulas, Graser, Habib, Hotz, Hsu, Inke Näthke, Ishikawa, Izumi, Izumi, Januschke, Januschke, Januschke, Jauffred, Jens Januschke, Johnston, Juanes, Kai, Knoblich, Konno, Kouzarides, Lander, Lansdorp, Lechler, Lerit, Liakopoulos, Lim, Lu, Lu, Lécuyer, Mapelli, Merdes, Moore, Morin, Morin, Morrison, Neumüller, Nigg, Nipper, Ouellet, Paridaen, Pelletier, Pereira, Piel, Postiglione, Potten, Poulson, Quyn, Razafsky, Rebollo, Rebollo, Regan, Reiter, Rocheteau, Rogers, Rusan, Sato, Segalen, Segalen, Shaw, Shitamukai, Siller, Siller, Smith, Speicher, Tajbakhsh, Takeda, Tian, Tran, Vorobjev, Wall, Wang, Wang, Wang, Werts, Williams, Wu, Yadlapalli, Yadlapalli, Yamashita, Yamashita, Yamashita, Yennek, Yoshiura, Yu, Zou   +112 more
core   +2 more sources